Lasofoxifene Tartrate CAS 190791-29-8 Chiral Purity ≥99.0% Purity ≥98.0% (HPLC) API Hoʻomaʻemaʻe Kiʻekiʻe Kiʻi Hōʻike

Lasofoxifene Tartrate CAS 190791-29-8 Maʻemaʻe Chiral ≥99.0% Maʻemaʻe ≥98.0% (HPLC) API Maʻemaʻe Kiʻekiʻe

ʻO ka wehewehe pōkole:

Inoa Kemika: Lasofoxifene Tartrate

CAS: 190791-29-8

Ke 'ano: Pada ke'oke'o i ka pauka ke'oke'o

Maʻemaʻe Chiral: ≥99.0%Maʻemaʻe: ≥98.0% (HPLC)

I ka mālama ʻana i ka Postmenopausal Osteoporosis

API no ke kūlana kiʻekiʻe, hana kālepa

Inquiry: alvin@ruifuchem.com

E hoʻouna i ka leka uila iā mākou

Huahana Huahana

Nā Huahana Pili

Huahana Huahana

wehewehe:

Hāʻawi Mea Hana me ka Maʻemaʻe kiʻekiʻe a me ka maikaʻi paʻa
Inoa Kemika: Lasofoxifene Tartrate
CAS: 190791-29-8
Lasofoxifene Tartrate (CAS: 190791-29-8) i ka mālama ʻana i ka Postmenopausal Osteoporosis

Na Waiwai Kemika:

Inoa Kimia	ʻO Lasofoxifene Tartrate
Nā huaʻōlelo like	(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol Tartrate Oporia
Helu CAS	190791-29-8
Helu CAT	RF-API20
Kūlana Kūʻai	Ma ka waihona, ʻoi aku ka nui o ka hana a hiki i nā haneli kilogram
ʻĀpana Molekala	C28H31NO2.ClH
Kaumaha Molecular	450.019
Brand	Kemika Ruifu

Nā kikoʻī:

'ikamu	Nā kikoʻī
Ka nana aku	Keʻokeʻo a hiki i ka pauda keʻokeʻo
Māmā (KF)	≤0.50%
Nā Metala Kaumaha	≤20ppm
Maʻemaʻe Chiral	≥99.0%
Maʻemaʻe / Kaʻina Hanana	≥98.0% (HPLC)
Nalo ma ka maloo	≤0.50%
Koena ma ka Ignition	≤0.50%
Kūlana hoʻāʻo	Pākē Pharmacopoeia (CP);Kūlana ʻoihana
Hoʻohana	Mea Hana Lapaʻau Hoʻoikaika (API);ʻOsteoporosis postmenopausal

Pūʻolo a me ka waiho ʻana:

Pūʻolo: ʻO ka ʻōmole, ʻeke ʻeke alumini, pahu pahu pahu, 25kg / pahu, a i ʻole e like me ka makemake o ka mea kūʻai aku.

Kūlana mālama:E mālama i loko o nā pahu i hoʻopaʻa ʻia ma kahi maloʻo a maloʻo;Palekana mai ka malamalama, ka ma'ū a me ka pest infestation.

Pono:

FAQ:

Noi:

ʻO Shanghai Ruifu Chemical Co., Ltd. ka mea hana nui a me ka mea hoʻolako o Lasofoxifene Tartrate (CAS: 190791-29-8) me ke ʻano kiʻekiʻe.
ʻO Lasofoxifene Tartrate he kolu o ka hanauna, non-steroidal selective estrogen receptor modulator (SERM).Hoʻopili paʻa ʻo ia i ka ERalpha kanaka me ka waiwai IC50 o 1.5 nM a pale i ka nalowale o ka iwi ma nā ʻiole ovariectomized.I loko o nā haʻawina hauʻoli o ka osteoporosis postmenopausal, ua pili ka 0.5 mg / lā lasofoxifene me ka hōʻemi ʻana i nā pilikia o ka nonvertebral a me ka vertebral fractures, ER-positive breast cancer, coronary heart disease, a me ka hahau akā ua piʻi ka pilikia o nā hanana thromboembolic venous.Ua hōʻike pū ʻia ʻo Lasofoxifene e hana ma ke ʻano he agonist inverse ma ka CB2 cannabinoid receptor, e hōʻike ana i kona hiki ke hoʻihoʻi hou ʻia ma ke ʻano he therapeutic no nā hōʻailona kahi CB2 i pahuhopu.